
From GWAS to Drugs explores how artificial intelligence can bridge the gap between genome-wide association studies (GWAS) and real-world drug discovery. Aimed at students, researchers, and professionals, the book provides a guided overview of how computational tools are transforming genetic associations into therapeutic targets—making the path from data to drug more actionable than ever.
Nous publions uniquement les avis qui respectent les conditions requises. Consultez nos conditions pour les avis.